An innovative biotechnology company exploring novel therapeutics for neuroscience indications had developed a promising new chemical entity for the treatment of a severe pediatric genetic disease.
The significant interest in semi-solid systems for the potential of extended release profiles has prompted researchers to develop alternative encapsulating systems.
Biogen’s Cambridge Manufacturing Facility leaders assessed their paper-based SOP delivery system. Their findings were that their procedures were inefficient and costly.
This paper explores design arrangements to cope with higher-load applications and identifies design considerations observed during the development of a high-load, twin rail system.
Advancements open a new range of applications to the use of intelligent, networked valve manifold I/O. The new hardware makes it possible to gain advantages in labor savings and diagnostic capability.
The drive toward sustainable, “green” processes in biopharmaceuticals seems like a daunting challenge. However, the right tools can integrate “green” practices into every aspect of the development workflow. This case study explores how one BIOVIA customer rolled out BIOVIA Workbook across its process chemistry division to around 1,000 scientists and the “green” benefits the group saw.
A commercial stage medical technology company has developed SMART Softgels featuring a special shell to release quickly while still preventing evaporative loss during and after manufacturing.
This article takes an in-depth look at how lipid-based drug delivery systems can be used as a bioavailability enhancing technology, as well as the softgel dosage form for their delivery.
Targeted Oncology™, a print and digital resource that offers content and expert opinions on precision medicine in oncology, will launch the first Expert Perspective: Virtual Tumor Board on April 24